NASDAQ:EPZM
Delisted
Epizyme Stock News
$1.47
+0 (+0%)
At Close: Nov 10, 2022
Analysts Issue Forecasts for Epizyme Inc's Q4 2020 Earnings (NASDAQ:EPZM)
10:26am, Saturday, 02'nd May 2020
Epizyme Inc (NASDAQ:EPZM) – Equities research analysts at SVB Leerink lifted their Q4 2020 earnings per share estimates for Epizyme in a research note issued to investors on Monday, April 27th. SVB
Epizyme (EPZM) Scheduled to Post Earnings on Monday
06:18am, Saturday, 02'nd May 2020
Epizyme (NASDAQ:EPZM) is set to release its earnings data before the market opens on Monday, May 4th. Analysts expect Epizyme to post earnings of ($0.74) per share for the quarter. Persons that wish t
Q4 2020 Earnings Forecast for Epizyme Inc (NASDAQ:EPZM) Issued By SVB Leerink
08:30am, Friday, 01'st May 2020
Epizyme Inc (NASDAQ:EPZM) – Stock analysts at SVB Leerink lifted their Q4 2020 earnings per share (EPS) estimates for shares of Epizyme in a research note issued to investors on Monday, April 27th.
NI sisters raise £20k for blood cancer charity in just 12 hours
08:14pm, Monday, 27'th Apr 2020
The girls wanted to do something special to mark the end of Anita's chemotherapy treatment
Earnings Preview: Epizyme (EPZM) Q1 Earnings Expected to Decline
04:32pm, Monday, 27'th Apr 2020
Epizyme (EPZM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Epizyme (EPZM) Q1 Earnings Expected to Decline
04:32pm, Monday, 27'th Apr 2020
Epizyme (EPZM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Epizyme Announces Date of First Quarter 2020 Financial Results
10:30am, Monday, 27'th Apr 2020
Epizyme, Inc. (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing novel epigenetic therapies, today announced that management will host a conference call and webc
Earnings Preview: Epizyme (EPZM) Q1 Earnings Expected to Decline
12:00am, Monday, 27'th Apr 2020Is Epizyme, Inc.'s (NASDAQ:EPZM) CEO Overpaid Relative To Its Peers?
02:02pm, Sunday, 26'th Apr 2020
Bob Bazemore became the CEO of Epizyme, Inc. (NASDAQ:EPZM) in 2015. This report will, first, examine the CEO...
Epizyme Inc (NASDAQ:EPZM) Given Consensus Rating of "Buy" by Analysts
07:00am, Saturday, 25'th Apr 2020
Shares of Epizyme Inc (NASDAQ:EPZM) have earned an average rating of “Buy” from the ten research firms that are presently covering the stock, MarketBeat reports. One equities research analyst has
Bank of America Corp DE Has $951,000 Stock Position in Epizyme Inc (NASDAQ:EPZM)
09:12am, Friday, 24'th Apr 2020
Bank of America Corp DE trimmed its holdings in shares of Epizyme Inc (NASDAQ:EPZM) by 18.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and
Nuveen Asset Management LLC Purchases 21,114 Shares of Epizyme Inc (NASDAQ:EPZM)
10:52am, Monday, 20'th Apr 2020
Nuveen Asset Management LLC increased its stake in shares of Epizyme Inc (NASDAQ:EPZM) by 6.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commissio
3 Top Biotech Stocks with FDA Approvals on the Horizon
11:02am, Sunday, 19'th Apr 2020
COVID-19 has turned the world upside down, but the market’s most recent surge has Wall Street observers wondering if the situation is on the mend. Rallying on April 17 thanks to encouraging data fro
3 "Strong Buy" Biotech Stocks with FDA Approvals on the Horizon
11:01am, Sunday, 19'th Apr 2020
COVID-19 has turned the world upside down, but the market’s most recent surge has Wall Street observers wondering if the situation is on the
Norges Bank Purchases Shares of 885,617 Epizyme Inc (NASDAQ:EPZM)
09:30am, Saturday, 18'th Apr 2020
Norges Bank purchased a new stake in Epizyme Inc (NASDAQ:EPZM) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased
